Description
5-Amino-1MQ / SLU-PP-332 Technical Overview
5-Amino-1MQ / SLU-PP-332 is a dual-compound research formulation combining two chemically distinct small molecules investigated in metabolic research.
5-Amino-1MQ is a quinolinium-based compound studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide methylation.
SLU-PP-332 is an experimental agonist of estrogen-related receptors (ERRs), nuclear receptors associated with transcriptional regulation of metabolic pathways.
These compounds have different molecular targets. Their combined activity and stability cannot be established from separate research findings.
Compound Specifications
| Property | Value |
|---|---|
| Product Name | 5-Amino-1MQ / SLU-PP-332 |
| Component 1 | 5-Amino-1MQ |
| Component 1 Target | NNMT |
| Component 2 | SLU-PP-332 |
| Component 2 Targets | ERRα, ERRβ, ERRγ |
| Classification | Dual small-molecule research formulation |
| Peptide Sequence | Not applicable |
| Individual Component Amounts | Not specified |
| Total Product Content | Not specified in product title |
Storage and Handling
- Follow manufacturer-provided stability conditions.
- Protect from moisture and contamination.
- Use formulation-specific compatibility information.
Lyophilized Format
Both components are small organic molecules rather than peptides. The physical form of their combination depends on the formulation.
Research Use Disclaimer
This experimental combination is not FDA-approved for therapeutic use and is not intended for human or veterinary administration.
Frequently Asked Questions
What Is 5-Amino-1MQ?
A synthetic NNMT inhibitor investigated in metabolic research.
What Is SLU-PP-332?
An experimental estrogen-related receptor agonist.
Are These Compounds Peptides?
No. Both are small molecules.
What Research Areas Involve the Combination?
NNMT activity, nicotinamide metabolism, nuclear receptor signaling, and formulation science.
Has the Combination Been Clinically Validated?
No established clinical efficacy or safety has been demonstrated for the combination.
Research Overview
The formulation combines two compounds associated with different metabolic regulatory mechanisms.
NNMT Inhibition Research
5-Amino-1MQ has been investigated for its effects on NNMT catalytic activity and nicotinamide-associated metabolism.
ERR Signaling Research
SLU-PP-332 has been studied in experimental models examining estrogen-related receptor activation and metabolic gene regulation.
Combination Research
Combined preparations require independent investigation of chemical compatibility and cellular responses.
Research Applications
| Research Area | In Vitro Application |
|---|---|
| NNMT Research | Enzyme inhibition assays |
| ERR Research | Nuclear receptor reporter assays |
| Metabolic Biology | Gene expression analysis |
| Formulation Science | Component stability measurements |
References
- Neelakantan H, et al. (2018). Selective and Membrane-Permeable Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Reverse High Fat Diet-Induced Obesity in Mice. Biochemical Pharmacology. View publication.
- SLU-PP-332 ERR Research — PubMed.
Certificate of Analysis (COA)
Documentation should identify both compounds, their chemical forms, individual quantities, purity, and combined formulation characteristics.
Reviews
There are no reviews yet.